PPARGC1A and Alzheimer disease: These pathways can lead to alleviating effects in neurodegenerative diseases, such as Alzheimer’s disease and amyotrophic lateral sclerosis via, for example, SIRT1-generated deacetylation (and activation) of PGC-1α [94].